MBCP Safety and Performance in the Osteonecrosis of Femur Head
Primary Purpose
Osteonecrosis
Status
Unknown status
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
MBCP
Sponsored by
About this trial
This is an interventional treatment trial for Osteonecrosis focused on measuring Femur head aseptic osteonecrosis, Bone reconstruction, Macroporous biphasic calcium phosphate granules
Eligibility Criteria
Inclusion Criteria: femur head osteonecrosis (1 to 2 level in ARCO scale) signed informed consent Exclusion Criteria: primary bone infection femur head sphericity loss cancer, diabetes, tuberculosis previous history HIV, Hepatitis B, Hepatitis C infection drepanocytosis current corticotherapy current immunosuppressive therapy innate or acquired immune deficience pregnancy or lack of efficient contraception current participation in an other study
Sites / Locations
- Service de chirurgie orthopédique et traumatologique- Hôpital PellegrinRecruiting
Outcomes
Primary Outcome Measures
Infection and inflammation of the drilled area (blood and clinical assessment).
Adverse events.
Secondary Outcome Measures
Pain (Analogic Visual Scale)
Hip function
Bone reconstruction evaluation through scanner and radiography
Full Information
NCT ID
NCT00289575
First Posted
February 9, 2006
Last Updated
March 1, 2007
Sponsor
Biomatlante
Collaborators
CIC Bordeaux
1. Study Identification
Unique Protocol Identification Number
NCT00289575
Brief Title
MBCP Safety and Performance in the Osteonecrosis of Femur Head
Official Title
Evaluation of Safety and Performance of Macroporous Biphasic Calcium Phosphate Granules Combined With Cellulosic-Derived Gel, in Filling Bones Gap After Aseptic Osteonecrosis Biopsy of Femur Head.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2007
Overall Recruitment Status
Unknown status
Study Start Date
February 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2008 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Biomatlante
Collaborators
CIC Bordeaux
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this pilot study is to evaluate MBCP performance in bone regeneration after osteonecrosis biopsy of the femur head. This technic may prevent the neck of the femur bone weakness following the healthy area drilling, thanks to a bone reconstruction at the expense of the biomaterial.
Detailed Description
Twelve patients will be enrolled in this study and evaluation of infection and inflammation of the drilled area, pain and hip function will be assessed during a one year follow up. Bone reconstruction will be evaluated with scanner and radiography.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteonecrosis
Keywords
Femur head aseptic osteonecrosis, Bone reconstruction, Macroporous biphasic calcium phosphate granules
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
12 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
MBCP
Primary Outcome Measure Information:
Title
Infection and inflammation of the drilled area (blood and clinical assessment).
Title
Adverse events.
Secondary Outcome Measure Information:
Title
Pain (Analogic Visual Scale)
Title
Hip function
Title
Bone reconstruction evaluation through scanner and radiography
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
femur head osteonecrosis (1 to 2 level in ARCO scale)
signed informed consent
Exclusion Criteria:
primary bone infection
femur head sphericity loss
cancer, diabetes, tuberculosis previous history
HIV, Hepatitis B, Hepatitis C infection
drepanocytosis
current corticotherapy
current immunosuppressive therapy
innate or acquired immune deficience
pregnancy or lack of efficient contraception
current participation in an other study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thierry FABRE, Pr
Phone
+33556795544
Email
thierry.fabre@chu-bordeaux.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Dominique CHAUVEAUX, Pr
Phone
+33556795679
Email
dominique.chauveaux@chu-bordeaux.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, Pr
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jacques DEMOTES-MAINARD, Pr
Organizational Affiliation
Clinical Research Center INSERM/Bordeaux University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Service de chirurgie orthopédique et traumatologique- Hôpital Pellegrin
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, ¨Pr
Phone
+33556795544
Email
thierry.fabre@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Dominique CHAUVEAUX, pr
Phone
+33556795679
Email
dominique.chauveaux@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Thierry FABRE, Pr
12. IPD Sharing Statement
Learn more about this trial
MBCP Safety and Performance in the Osteonecrosis of Femur Head
We'll reach out to this number within 24 hrs